Krantz, Carsten (2016) 2016 White Paper on Recent Issues in Bioanalysis: Focus on Biomarker Assay Validation (BAV) (Part 2 – Hybrid LBA/LCMS and Input from Regulatory Agencies). Bioanalysis, 8 (23). pp. 2457-2474. ISSN bio-2016-4988

Abstract

This year marked the 10th anniversary edition of the Workshop on Recent Issues in Bioanalysis (10th WRIB), which was held in Orlando, Florida from April 18-22, 2016. Nearly 700 professionals from pharmaceutical/biopharmaceutical companies, biotechnology companies, contract research organizations (CROs), and regulatory agencies worldwide were in attendance. In addition to the 3 focused and sequential workshop days, there were 6 advanced training sessions throughout the week providing attendees multiple choices to combine core workshop days and training, thereby maximizing their learning process in many fields of drug development expertise. As with prior WRIBs, this 10th edition was specifically designed to facilitate sharing, reviewing, discussing and agreeing upon scientific and regulatory approaches to address the most recent issues in both small and large molecule bioanalysis, biomarkers, and immunogenicity. The areas of interest included LCMS, hybrid LBA/LCMS as well as LBA/cell-based approaches.

Item Type:	Article
Date Deposited:	01 Feb 2017 00:45
Last Modified:	01 Feb 2017 00:45
URI:	https://oak.novartis.com/id/eprint/30873